{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:26:09Z","timestamp":1778628369865,"version":"3.51.4"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jns.2021.117531","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T01:10:07Z","timestamp":1623373807000},"page":"117531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Neuroimaging findings in rheumatologic disorders"],"prefix":"10.1016","volume":"427","author":[{"given":"Sedat Giray","family":"Kandemirli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Bathla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/qjmed\/hcl005","article-title":"Neurological involvement in patients with rheumatic disease","volume":"99","author":"Sofat","year":"2006","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0010","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0961203316674820","article-title":"Advanced MRI techniques: biomarkers in neuropsychiatric lupus","volume":"26","author":"Sarbu","year":"2017","journal-title":"Lupus."},{"issue":"11","key":"10.1016\/j.jns.2021.117531_bb0015","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.acra.2016.03.019","article-title":"MR diffusion tractography to identify and characterize microstructural white matter tract changes in systemic lupus erythematosus patients","volume":"23","author":"Shastri","year":"2016","journal-title":"Acad. Radiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0020","first-page":"546","article-title":"Proton magnetic resonance spectroscopy reveals central neuroaxonal impairment in systemic sclerosis","volume":"33","author":"Bertinotti","year":"2006","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.jns.2021.117531_bb0025","first-page":"1091","article-title":"Resting-state fMRI in primary Sjogren syndrome","volume":"59","author":"Xing","year":"2018","journal-title":"Acta radiologica (Stockholm, Sweden\u202f: 1987)"},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2017.06.003","article-title":"Central nervous system manifestations of systemic lupus erythematosus","volume":"43","author":"Jafri","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ncl.2009.09.004","article-title":"Neurologic manifestations of systemic lupus erythematosus in children and adults","volume":"28","author":"Muscal","year":"2010","journal-title":"Neurol. Clin."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/rheumatology\/keu458","article-title":"Attribution in the assessment of nervous system disease in SLE","volume":"54","author":"Hanly","year":"2015","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/rheumatology\/keu384","article-title":"Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus","volume":"54","author":"Bortoluzzi","year":"2015","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0060","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1148\/rg.244985082","article-title":"Imaging findings in systemic lupus erythematosus","volume":"24","author":"Lalani","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.jns.2021.117531_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nicl.2015.05.002","article-title":"A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus","volume":"8","author":"Ercan","year":"2015","journal-title":"NeuroImage Clin."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00296-014-3150-8","article-title":"Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions","volume":"35","author":"Jeong","year":"2015","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0075","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/jmri.25966","article-title":"Intracranial vessel wall lesions in patients with systematic lupus erythematosus","volume":"48","author":"Ide","year":"2018","journal-title":"JMRI"},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.autrev.2007.11.022","article-title":"Optimizing clinical monitoring of central nervous system involvement in SLE","volume":"7","author":"Castellino","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12016-007-8060-z","article-title":"Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus","volume":"34","author":"Appenzeller","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.21483","article-title":"Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients","volume":"64","author":"Appenzeller","year":"2008","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0095","first-page":"385","article-title":"Cognitive dysfunction and white matter abnormalities in systemic lupus erythematosus","volume":"17","author":"Kozora","year":"2011","journal-title":"JINS"},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"63","author":"Luyendijk","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10067-017-3891-3","article-title":"Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus","volume":"37","author":"Tan","year":"2018","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.25146","article-title":"Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies","volume":"83","author":"Maggi","year":"2018","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0899-7071(03)00191-8","article-title":"CNS vasculitis and vasculopathy: efficacy and usefulness of diffusion-weighted echoplanar MR imaging","volume":"28","author":"Moritani","year":"2004","journal-title":"Clin. Imaging"},{"issue":"8","key":"10.1016\/j.jns.2021.117531_bb0120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1076-6332(03)80581-0","article-title":"Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus","volume":"8","author":"Moritani","year":"2001","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.jns.2021.117531_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nicl.2014.07.001","article-title":"Diminished white matter integrity in patients with systemic lupus erythematosus","volume":"5","author":"Schmidt-Wilcke","year":"2014","journal-title":"NeuroImage Clin."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0130","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3899\/jrheum.090967","article-title":"White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging","volume":"37","author":"Xu","year":"2010","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0135","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neuroimage.2006.09.029","article-title":"Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus","volume":"34","author":"Appenzeller","year":"2007","journal-title":"NeuroImage."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0140","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.1371\/journal.pone.0009302","article-title":"Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus","volume":"5","author":"Jung","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0145","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.acra.2013.07.011","article-title":"Reduced insular glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study","volume":"20","author":"Cagnoli","year":"2013","journal-title":"Acad. Radiol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.crad.2012.06.110","article-title":"Imaging of systemic lupus erythematosus. Part I: CNS, cardiovascular, and thoracic manifestations","volume":"68","author":"Goh","year":"2013","journal-title":"Clin. Radiol."},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0155","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/096120330000900708","article-title":"Subarachnoid hemorrhage and systemic lupus erythematosus","volume":"9","author":"Mimori","year":"2000","journal-title":"Lupus."},{"issue":"12","key":"10.1016\/j.jns.2021.117531_bb0160","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.amjmed.2005.05.026","article-title":"Stroke subtypes among young patients with systemic lupus erythematosus","volume":"118","author":"Krishnan","year":"2005","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3174\/ajnr.A3645","article-title":"Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome","volume":"35","author":"Kaichi","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0170","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/1756-185X.12337","article-title":"Neuro-ophthalmologic manifestations of systemic lupus erythematosus: a systematic review","volume":"17","author":"Man","year":"2014","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0961203314547795","article-title":"Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients","volume":"24","author":"Saison","year":"2015","journal-title":"Lupus."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.01.011","article-title":"Demyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis","volume":"16","author":"Piga","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.jns.2021.117531_bb0185","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/jnnp-2014-309761","article-title":"Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder?","volume":"86","author":"Hyun","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/rg.2018170141","article-title":"Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis","volume":"38","author":"Dutra","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.jns.2021.117531_bb0195","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0200","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2017.06.002","article-title":"Neurologic manifestations of primary Sjogren syndrome","volume":"43","author":"Margaretten","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.2004.025676","article-title":"Primary Sj\u00f6gren\u2019s syndrome: new clinical and therapeutic concepts","volume":"64","author":"Ramos-Casals","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0210","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","article-title":"Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients","volume":"83","author":"Delalande","year":"2004","journal-title":"Medicine."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0215","doi-asserted-by":"crossref","first-page":"e84605","DOI":"10.1371\/journal.pone.0084605","article-title":"Neurological involvement in primary Sj\u00f6gren syndrome: a focus on central nervous system","volume":"9","author":"Morreale","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.semarthrit.2004.07.005","article-title":"Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging","volume":"34","author":"Morgen","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0225","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2003.019497","article-title":"Central nervous system involvement in Sj\u00f6gren\u2019s syndrome","volume":"63","author":"Soliotis","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13256-019-2086-8","article-title":"Peripheral and central nervous system involvement in a patient with primary Sj\u00f6gren\u2019s syndrome: a case report","volume":"13","author":"Ging","year":"2019","journal-title":"J. Med. Case Rep."},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0235","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3174\/ajnr.A1204","article-title":"Primary Sjogren syndrome with tumefactive central nervous system involvement","volume":"29","author":"Sanahuja","year":"2008","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0240","first-page":"1301","article-title":"Cerebral white matter lesions in primary Sjogren\u2019s syndrome: a controlled study","volume":"26","author":"Coates","year":"1999","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0245","first-page":"239","article-title":"Central nervous system disease in Sjogren\u2019s syndrome","volume":"146","author":"Escudero","year":"1995","journal-title":"Ann. Med. Interne"},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0250","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2214\/AJR.10.5984","article-title":"CNS involvement in primary Sjogren syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry","volume":"197","author":"Tzarouchi","year":"2011","journal-title":"AJR Am. J. Roentgenol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0255","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0972-2327.53083","article-title":"Primary Sj\u00f6gren\u2019s syndrome manifesting as multiple cranial neuropathies: MRI findings","volume":"12","author":"Ashraf","year":"2009","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0260","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.clineuro.2005.05.015","article-title":"Subacute aseptic meningitis as neurological manifestation of primary Sjogren\u2019s syndrome","volume":"108","author":"Rossi","year":"2006","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"9","key":"10.1016\/j.jns.2021.117531_bb0265","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1352458509106228","article-title":"Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica","volume":"15","author":"Min","year":"2009","journal-title":"Mult. Scler."},{"issue":"8","key":"10.1016\/j.jns.2021.117531_bb0270","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/rheumatology\/keq070","article-title":"Disruption of brain white matter microstructure in primary Sjogren\u2019s syndrome: evidence from diffusion tensor imaging","volume":"49","author":"Segal","year":"2010","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0275","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3174\/ajnr.A3756","article-title":"White matter water diffusion changes in primary Sjogren syndrome","volume":"35","author":"Tzarouchi","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0280","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semarthrit.2013.05.002","article-title":"Neurologic involvement in scleroderma: a systematic review","volume":"43","author":"Amaral","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0290","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0031-3955(16)40058-1","article-title":"Scleroderma in children","volume":"42","author":"Uziel","year":"1995","journal-title":"Pediatr. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0295","first-page":"7","article-title":"When is scleroderma not scleroderma? The differential diagnosis of progressive systemic sclerosis","volume":"31","author":"Rodnan","year":"1981","journal-title":"Bull. Rheum. Dis."},{"issue":"19","key":"10.1016\/j.jns.2021.117531_bb0300","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/01.wnl.0000334474.88923.e3","article-title":"Neurologic manifestations of localized scleroderma: a case report and literature review","volume":"71","author":"Kister","year":"2008","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0305","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1542\/peds.2005-0470","article-title":"Linear scleroderma en coup de sabre with associated neurologic abnormalities","volume":"117","author":"Holland","year":"2006","journal-title":"Pediatrics."},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0310","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00256-013-1617-4","article-title":"Late-onset en coup de sabre of the skull","volume":"42","author":"Mohan","year":"2013","journal-title":"Skelet. Radiol."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0315","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/03009740600556126","article-title":"Linear scleroderma \u2018en coup de sabre\u2019 associated with cerebral and ocular vasculitis","volume":"35","author":"Holl-Wieden","year":"2006","journal-title":"Scand. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.jns.2021.117531_bb0320","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.WNL.0000124518.25087.18","article-title":"Neuroimaging findings in scleroderma en coup de sabre","volume":"62","author":"Appenzeller","year":"2004","journal-title":"Neurology."},{"issue":"11","key":"10.1016\/j.jns.2021.117531_bb0325","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/WNL.63.11.2197-b","article-title":"Neuroimaging findings in scleroderma en coup de sabre","volume":"63","author":"Chang","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0330","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/pde.12001","article-title":"A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings","volume":"29","author":"Chiu","year":"2012","journal-title":"Pediatr. Dermatol."},{"issue":"11","key":"10.1016\/j.jns.2021.117531_bb0335","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s00247-018-4177-x","article-title":"The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review","volume":"48","author":"Maloney","year":"2018","journal-title":"Pediatr. Radiol."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00234-014-1448-6","article-title":"CNS imaging findings associated with Parry-Romberg syndrome and en coup de sabre: correlation to dermatologic and neurologic abnormalities","volume":"57","author":"Doolittle","year":"2015","journal-title":"Neuroradiology."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0345","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.70.3.382","article-title":"Scleroderma \u201cen coup de sabre\u201d: pathological evidence of intracerebral inflammation","volume":"70","author":"Stone","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"24","key":"10.1016\/j.jns.2021.117531_bb0350","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1212\/01.wnl.0000295701.56822.6f","article-title":"Parry Romberg syndrome and linear scleroderma en coup de sabre mimicking Rasmussen encephalitis","volume":"69","author":"Echenne","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/s0387-7604(02)00147-x","article-title":"Linear scleroderma associated with progressive brain atrophy","volume":"25","author":"Grosso","year":"2003","journal-title":"Brain Dev."},{"issue":"12","key":"10.1016\/j.jns.2021.117531_bb0360","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00296-012-2614-y","article-title":"Acute cerebral vasculopathy in systemic sclerosis","volume":"33","author":"Faucher","year":"2013","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0365","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3899\/jrheum.081222","article-title":"Cerebral vasculopathy is associated with severe vascular manifestations in systemic sclerosis","volume":"36","author":"Terrier","year":"2009","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.jns.2021.117531_bb0370","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/rheumatology\/39.12.1366","article-title":"Evidence of cerebral hypoperfusion in scleroderma patients","volume":"39","author":"Cutolo","year":"2000","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0375","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000050795","article-title":"Cerebral vasculopathy showing moyamoya-like changes in a patient with CREST syndrome","volume":"46","author":"Terajima","year":"2001","journal-title":"Eur. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0380","first-page":"216","article-title":"Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities: comment to the authors","volume":"35 Suppl 106","author":"De Langhe","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3904\/kjim.2012.27.2.239","article-title":"Intracranial vasculopathy in a patient with systemic sclerosis: atherosclerotic or moyamoya-like disease?","volume":"27","author":"Choi","year":"2012","journal-title":"Korean J. Intern Med."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0390","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.berh.2019.02.003","article-title":"Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents","volume":"32","author":"Atzeni","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0395","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.rdc.2017.06.005","article-title":"Neurologic manifestations of rheumatoid arthritis","volume":"43","author":"DeQuattro","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"12","key":"10.1016\/j.jns.2021.117531_bb0400","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.autrev.2014.08.014","article-title":"Cervical spine involvement in rheumatoid arthritis--a systematic review","volume":"13","author":"Joaquim","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0405","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/ard.2005.042135","article-title":"High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery","volume":"65","author":"Neva","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0410","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jocn.2009.01.033","article-title":"MRI and pathological findings of rheumatoid meningitis","volume":"17","author":"Matsushima","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2021.117531_bb0415","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-208745","article-title":"Rheumatoid meningitis: a rare complication of rheumatoid arthritis","volume":"2015","author":"Lu","year":"2015","journal-title":"BMJ Case Rep."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0420","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1552-6569.2005.tb00325.x","article-title":"An unusual presentation of rheumatoid meningitis","volume":"15","author":"Chowdhry","year":"2005","journal-title":"J. Neuroimaging"},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0425","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jbspin.2010.02.030","article-title":"Isolated cerebral vasculitis associated with rheumatoid arthritis","volume":"77","author":"Caballol Pons","year":"2010","journal-title":"Joint, Bone, Spine\u202f: Revue du Rhumatisme."},{"issue":"17","key":"10.1016\/j.jns.2021.117531_bb0430","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1212\/WNL.0000000000000366","article-title":"Rheumatoid meningitis presenting with stroke-like episodes","volume":"82","author":"Bourgeois","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117531_bb0435","first-page":"84","article-title":"Rheumatoid meningitis","volume":"2","author":"Servioli","year":"2011","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0440","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10067-003-0788-0","article-title":"Rheumatoid meningitis: an autopsy report and review of the literature","volume":"22","author":"Kato","year":"2003","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0445","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neurad.2013.10.005","article-title":"MRI with DWI helps in depicting rheumatoid meningitis","volume":"41","author":"Roques","year":"2014","journal-title":"J. Neuroradiol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0450","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2176\/nmc.cr2012-0259","article-title":"Multiple intracranial nodules associated with rheumatoid arthritis: case report","volume":"54","author":"Takahashi","year":"2014","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0455","first-page":"237","article-title":"A case of rheumatoid nodule formation within the central nervous system and review of the literature","volume":"11","author":"Jackson","year":"1984","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.jns.2021.117531_bb0460","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00296-008-0810-6","article-title":"An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis","volume":"29","author":"Kurne","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"26","key":"10.1016\/j.jns.2021.117531_bb0465","doi-asserted-by":"crossref","first-page":"e3999","DOI":"10.1097\/MD.0000000000003999","article-title":"Increased incidence of rheumatoid arthritis in multiple sclerosis: a nationwide cohort study","volume":"95","author":"Tseng","year":"2016","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.jns.2021.117531_bb0470","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/ard.2009.111500","article-title":"Demyelinating events in rheumatoid arthritis after drug exposures","volume":"69","author":"Bernatsky","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0475","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00430-015-0390-5","article-title":"Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics","volume":"204","author":"Verheyen","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0480","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/art.20277","article-title":"The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions","volume":"50","author":"Schiff","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0485","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.clindermatol.2017.06.004","article-title":"Behcet disease: new aspects","volume":"35","author":"Bulur","year":"2017","journal-title":"Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1756285609347123","article-title":"Diagnosis and treatment of cerebral vasculitis","volume":"3","author":"Berlit","year":"2010","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0495","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1212\/WNL.41.3.405","article-title":"MRI findings in neuro-Behcet\u2019s disease","volume":"41","author":"Al Kawi","year":"1991","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2021.117531_bb0500","series-title":"Multiple Sclerosis and CNS Inflammatory Disorders","first-page":"178","article-title":"Neuro-Beh\u00e7et syndrome","author":"Siva","year":"2014"},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0505","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3174\/ajnr.A2477","article-title":"Evaluation of parenchymal neuro-behcet disease by using susceptibility-weighted imaging","volume":"32","author":"Albayram","year":"2011","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0510","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2004-815826","article-title":"MRI findings in pediatric neuro-Behcet\u2019s disease","volume":"35","author":"Saltik","year":"2004","journal-title":"Neuropediatrics."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0515","first-page":"1015","article-title":"CNS involvement in neuro-Behcet syndrome: an MR study","volume":"20","author":"Kocer","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0520","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1148\/rg.e31","article-title":"Radiologic and clinical findings of Behcet disease: comprehensive review of multisystemic involvement","volume":"28","author":"Chae","year":"2008","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0525","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00415-009-0145-6","article-title":"The spectrum of nervous system involvement in Behcet\u2019s syndrome and its differential diagnosis","volume":"256","author":"Siva","year":"2009","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0530","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","article-title":"Behcet\u2019s disease: diagnostic and prognostic aspects of neurological involvement","volume":"248","author":"Siva","year":"2001","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0535","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1177\/1352458515613642","article-title":"Spinal cord involvement in Behcet\u2019s disease","volume":"22","author":"Lee","year":"2016","journal-title":"Mult. Scler."},{"issue":"40","key":"10.1016\/j.jns.2021.117531_bb0540","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007958","article-title":"Clinical and imaging features of spinal cord type of neuro Behcet disease: a case report and systematic review","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0545","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.25004","article-title":"Myelopathy in Behcet\u2019s disease: the bagel sign","volume":"82","author":"Uygunoglu","year":"2017","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0550","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14737175.2015.1037288","article-title":"Neurosarcoidosis: diagnosis, therapy and biomarkers","volume":"15","author":"Bagnato","year":"2015","journal-title":"Expert. Rev. Neurother."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0555","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.crad.2015.09.007","article-title":"Imaging of neurosarcoidosis: common, uncommon, and rare","volume":"71","author":"Bathla","year":"2016","journal-title":"Clin. Radiol."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0560","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12883-016-0741-x","article-title":"Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis","volume":"16","author":"Fritz","year":"2016","journal-title":"BMC Neurol."},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0565","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.crad.2018.05.018","article-title":"Cerebrovascular manifestations in neurosarcoidosis: how common are they and does perivascular enhancement matter?","volume":"73","author":"Bathla","year":"2018","journal-title":"Clin. Radiol."},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0570","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3174\/ajnr.A5492","article-title":"Cerebrovascular manifestations of neurosarcoidosis: an underrecognized aspect of the imaging spectrum","volume":"39","author":"Bathla","year":"2018","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"12","key":"10.1016\/j.jns.2021.117531_bb0575","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis consortium consensus group","volume":"75","author":"Stern","year":"2018","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0580","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","article-title":"Central nervous system sarcoidosis--diagnosis and management","volume":"92","author":"Zajicek","year":"1999","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0585","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.38.3.378","article-title":"Magnetic resonance imaging in central nervous system sarcoidosis","volume":"38","author":"Miller","year":"1988","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0590","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3174\/ajnr.A1470","article-title":"Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis","volume":"30","author":"Shah","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0595","first-page":"185","article-title":"Neurosarcoidosis: evaluation with MRI","volume":"27","author":"Pickuth","year":"2000","journal-title":"J. Neuroradiol\/Journal de neuroradiologie."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0600","first-page":"1227","article-title":"CNS sarcoidosis: evaluation with contrast-enhanced MR imaging","volume":"12","author":"Seltzer","year":"1991","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0605","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.crad.2020.05.008","article-title":"Retrospective, dual-centre review of imaging findings in neurosarcoidosis at presentation: prevalence and imaging sub-types","volume":"75","author":"Bathla","year":"2020","journal-title":"Clin. Radiol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0610","first-page":"655","article-title":"MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment","volume":"20","author":"Christoforidis","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0615","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00415-018-9001-x","article-title":"Clinical, imaging, and histological presentations and outcomes of stroke related to sarcoidosis","volume":"265","author":"Jachiet","year":"2018","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2021.117531_bb0620","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3174\/ajnr.A5783","article-title":"Engorgement of deep medullary veins in neurosarcoidosis: a common-yet-underrecognized cerebrovascular finding on SWI","volume":"39","author":"Zamora","year":"2018","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0625","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0899-7071(03)00146-3","article-title":"Neurosarcoidosis: findings in MRI","volume":"28","author":"Fels","year":"2004","journal-title":"Clin. Imaging"},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0630","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcp042","article-title":"Presentations and outcomes of neurosarcoidosis: a study of 54 cases","volume":"102","author":"Pawate","year":"2009","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0635","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.crad.2016.02.006","article-title":"Lymphomatous involvement of the central nervous system","volume":"71","author":"Bathla","year":"2016","journal-title":"Clin. Radiol."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0640","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.2008.151977","article-title":"Neurosarcoidosis: a study of 30 new cases","volume":"80","author":"Joseph","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0645","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1971400918806634","article-title":"Imaging findings in spinal sarcoidosis: a report of 18 cases and review of the current literature","volume":"32","author":"Soni","year":"2019","journal-title":"Neuroradiol. J."},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0650","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000002992","article-title":"Central canal enhancement and the trident sign in spinal cord sarcoidosis","volume":"87","author":"Zalewski","year":"2016","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0655","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/WNL.43.2.333","article-title":"Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics","volume":"43","author":"Junger","year":"1993","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0660","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0665","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.rdc.2017.06.010","article-title":"Neurologic features of immunoglobulin G4-related disease","volume":"43","author":"AbdelRazek","year":"2017","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0670","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","article-title":"IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry","volume":"91","author":"Ebbo","year":"2012","journal-title":"Medicine."},{"issue":"9","key":"10.1016\/j.jns.2021.117531_bb0675","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheum."},{"issue":"15","key":"10.1016\/j.jns.2021.117531_bb0680","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0685","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3171\/2011.7.JNS1166","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis involving cerebral parenchyma","volume":"115","author":"Kim","year":"2011","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0690","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamaneurol.2014.40","article-title":"Central nervous system manifestation of IgG4-related disease","volume":"71","author":"Regev","year":"2014","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0695","doi-asserted-by":"crossref","first-page":"e6205","DOI":"10.1097\/MD.0000000000006205","article-title":"Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series","volume":"96","author":"Ebbo","year":"2017","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0700","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0705","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejrad.2009.06.010","article-title":"Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis","volume":"76","author":"Fujinaga","year":"2010","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0710","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00330-016-4481-5","article-title":"Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign","volume":"27","author":"Soussan","year":"2017","journal-title":"Eur. Radiol."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0715","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-015-0530-4","article-title":"IgG4-related ophthalmic disease: pooling of published cases and literature review","volume":"15","author":"Wu","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"10.1016\/j.jns.2021.117531_bb0720","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3174\/ajnr.A3865","article-title":"Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients","volume":"35","author":"Tiegs-Heiden","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"9","key":"10.1016\/j.jns.2021.117531_bb0725","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.crad.2011.03.018","article-title":"Idiopathic orbital pseudotumour","volume":"66","author":"Ding","year":"2011","journal-title":"Clin. Radiol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0730","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10384-012-0151-6","article-title":"The usefulness of infraorbital nerve enlargement on MRI imaging in clinical diagnosis of IgG4-related orbital disease","volume":"56","author":"Ohshima","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0735","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(17)30471-4","article-title":"IgG4-related disease of the central and peripheral nervous systems","volume":"17","author":"AbdelRazek","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.117531_bb0740","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000568","article-title":"Immunoglobulin G4-related hypertrophic pachymeningitis","volume":"6","author":"Levraut","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflammation."},{"issue":"10","key":"10.1016\/j.jns.2021.117531_bb0745","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0750","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11102-013-0498-9","article-title":"Hypophysitis due to IgG4-related disease responding to treatment with azathioprine: an alternative to corticosteroid therapy","volume":"17","author":"Caputo","year":"2014","journal-title":"Pituitary."},{"issue":"8","key":"10.1016\/j.jns.2021.117531_bb0755","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.autrev.2008.04.016","article-title":"Pituitary autoimmunity: 30 years later","volume":"7","author":"Caturegli","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.jns.2021.117531_bb0760","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00234-012-1012-1","article-title":"Radiological features of IgG4-related disease in the head, neck, and brain","volume":"54","author":"Katsura","year":"2012","journal-title":"Neuroradiology."},{"issue":"11","key":"10.1016\/j.jns.2021.117531_bb0765","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3174\/ajnr.A3147","article-title":"MR imaging of IgG4-related disease in the head and neck and brain","volume":"33","author":"Toyoda","year":"2012","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.jns.2021.117531_bb0770","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"Bando","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0775","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QCO.0000000000000332","article-title":"Lyme neuroborreliosis","volume":"30","author":"Koedel","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jns.2021.117531_bb0780","first-page":"833","article-title":"Imaging in Lyme neuroborreliosis","volume":"9","author":"Lindland","year":"2018","journal-title":"Insights Iimag."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0785","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3174\/ajnr.A1579","article-title":"Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis","volume":"30","author":"Hildenbrand","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"8","key":"10.1016\/j.jns.2021.117531_bb0790","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00415-019-09359-0","article-title":"Neuronal loss or dysfunction in patients with early Lyme neuroborreliosis: a proton magnetic resonance spectroscopy study of the brain","volume":"266","author":"Garkowski","year":"2019","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0795","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12879-016-2112-z","article-title":"Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization","volume":"17","author":"Schwenkenbecher","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.jns.2021.117531_bb0800","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.nbd.2009.11.016","article-title":"Inflammation and central nervous system Lyme disease","volume":"37","author":"Fallon","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.jns.2021.117531_bb0805","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1148\/radiol.2531081103","article-title":"Neuro-Lyme disease: MR imaging findings","volume":"253","author":"Agarwal","year":"2009","journal-title":"Radiology."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0810","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0887-8994(92)90003-H","article-title":"MRI findings in children infected by Borrelia burgdorferi","volume":"8","author":"Belman","year":"1992","journal-title":"Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.117531_bb0815","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00415-013-6831-4","article-title":"Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life","volume":"260","author":"Back","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.117531_bb0820","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fneur.2017.00146","article-title":"Cerebrovascular manifestations of Lyme neuroborreliosis-a systematic review of published cases","volume":"8","author":"Garkowski","year":"2017","journal-title":"Front. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:57:18Z","timestamp":1758383838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21002252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":164,"alternative-id":["S0022510X21002252"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117531","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroimaging findings in rheumatologic disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117531"}}